Amgen's cholesterol drug shows positive effect in cardiovascular outcomes study – Pharmaceutical Business Review

20. March 2017 Health, HIPAA 0
U.S. News & World Report Amgen’s cholesterol drug shows positive effect in cardiovascular outcomes studyPharmaceutical Business ReviewAmgen’s cholesterol drug Repatha (evolocumab) has showed positive effect in a 27,564-patient cardiovascular outcomes study. The trial demonstrated that Repatha has maximum reduced low-density lipoprotein cholesterol (LDL-C) levels, helping to …AMGN On Watch, GALE Reports Positive Data, EBS Secures BARDA ...

People of Bolivian Amazon have worlds healthiest hearts – India Today

19. March 2017 Health, HIPAA 0
The Nation People of Bolivian Amazon have worlds healthiest heartsIndia TodayWashington, Mar 19 (PTI) The Tsimane people in the forests of Bolivia have the healthiest arteries found anywhere in the world, a new study published in The Lancet journal claims. The Tsimane, a forager-horticulturalist population indigenous to the …Tsimane Tribe Has The World’s Healthiest Hearts, ...

Amgen: Low LDL Levels With Repatha Did Not Affect Cognitive Function In Study – Nasdaq

18. March 2017 Health, HIPAA 0
New York Times Amgen: Low LDL Levels With Repatha Did Not Affect Cognitive Function In StudyNasdaq(RTTNews.com) – Amgen Inc. ( AMGN ) announced results from the Repatha or evolocumab cognitive function trial (EBBINGHAUS) evaluating the impact on cognitive function in 1,974 patients enrolled in the Repatha cardiovascular outcomes study, …Cholesterol-Slashing Drug Can Protect High-Risk Heart Patients, ...